comparemela.com

Latest Breaking News On - Raghav mahobe - Page 1 : comparemela.com

EU regulator backs Pfizer's RSV vaccine for infants, older adults

EU regulator backs Pfizer's RSV vaccine for infants, older adults
gazette.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gazette.com Daily Mail and Mail on Sunday newspapers.

United-states
Bengaluru
Karnataka
India
Bhanvi-satija
Raghav-mahobe
Devika-syamnath
Pfizer
European-medicines-agency
Reuters
Astrazeneca
European-commission

Kenvue forecasts profit above estimates on self-care demand

Consumers prioritizing their dollars for essential, daily use products amid a cost-of-living crisis in some parts of the world has boosted companies such as Kenvue and peer Haleon. "While consumers may be trading down in more discretionary and traditional staple categories, we have not seen this dynamic in our portfolio," Kenvue CEO Thibaut Mongon said on a call with analysts, adding that health and wellness was still in focus. That helped Kenvue record a 12.2% rise in quarterly revenue for the self-care business, which houses over-the-counter products, or medicines that can be bought without a prescription.

Bengaluru
Karnataka
India
Devika-syamnath
Ananya-mariam-rajesh
Raghav-mahobe
Johnson
Reuters
Wall-street
Kenvue
Gross-profit-margin
Envue-ceo-thibaut-mongon

Kenvue quarterly sales rise on strong demand for self-care products

Kenvue on Thursday posted a rise in quarterly sales thanks to strong demand for its self-care and skincare brands such as Tylenol and Neutrogena. In its first results announcement since.

Bengaluru
Karnataka
India
Raghav-mahobe
Devika-syamnath
Ananya-mariam-rajesh
Johnson
Reuters
Markets

J&J spinoff Kenvue forecasts upbeat annual profit on self-care boost

J&J spinoff Kenvue forecasts upbeat annual profit on self-care boost
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.

Bengaluru
Karnataka
India
Raghav-mahobe
Devika-syamnath
Sriraj-kalluvila
Ananya-mariam-rajesh
Thibaut-mongon
Thomson-reuters-trust-principles
Reuters
Wall-street
Thomson-reuters-trust

Softbank-backed Neumora's depression drug cuts symptoms in mid-stage trial

Softbank-backed Neumora Therapeutics' experimental drug navacaprant has helped reduce symptoms of depression in patients with moderate-to-severe forms of the disorder in a mid-stage trial, the company said on Tuesday.

Bengaluru
Karnataka
India
United-states
American
Henry-gosebruch
Vaibhav-sadhamta
Paul-berns
Raghav-mahobe
Pooja-desai
Thomson-reuters-trust-principles
Reuters

vimarsana © 2020. All Rights Reserved.